IL10 and infection: Collectively, we demonstrated that MV130, a sublingual whole inactivated PBP that prevents infections in patients suffering from RRTIs, directly acts on human DCs promoting the generation of Th1/Th17 responses by mechanisms depending on NLR‐ and TLR‐mediated signalling pathways under the control of IL‐10.